Jack K. Tung

758 total citations
20 papers, 520 citations indexed

About

Jack K. Tung is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Jack K. Tung has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Jack K. Tung's work include Photoreceptor and optogenetics research (8 papers), Neuroscience and Neural Engineering (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jack K. Tung is often cited by papers focused on Photoreceptor and optogenetics research (8 papers), Neuroscience and Neural Engineering (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jack K. Tung collaborates with scholars based in United States and Taiwan. Jack K. Tung's co-authors include Robert E. Gross, Ken Berglund, Ute Hochgeschwender, Inn H. Yuk, Yongping Crawford, James L. Zehnder, Angela Meier, Bradley Snedecor, John C. Joly and Natarajan Vijayasankaran and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Cancer Research.

In The Last Decade

Jack K. Tung

17 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack K. Tung United States 12 290 213 136 64 42 20 520
Darin Zerti United Kingdom 16 582 2.0× 214 1.0× 57 0.4× 34 0.5× 36 0.9× 22 786
Philip Kusk Denmark 14 355 1.2× 216 1.0× 37 0.3× 43 0.7× 112 2.7× 24 651
G. Cederquist United States 11 619 2.1× 157 0.7× 162 1.2× 49 0.8× 119 2.8× 27 1.0k
Ayuko Sakane Japan 13 364 1.3× 93 0.4× 76 0.6× 46 0.7× 30 0.7× 25 695
Hui Gai United States 9 546 1.9× 84 0.4× 90 0.7× 14 0.2× 91 2.2× 9 691
Stephan Riesenberg Germany 10 625 2.2× 38 0.2× 140 1.0× 76 1.2× 111 2.6× 16 764
María Duran‐Moreno Spain 12 188 0.6× 79 0.4× 49 0.4× 33 0.5× 82 2.0× 17 520
Gokul N. Ramadoss United States 5 481 1.7× 60 0.3× 47 0.3× 96 1.5× 90 2.1× 6 644
Diderik Tirefort Switzerland 13 341 1.2× 78 0.4× 89 0.7× 19 0.3× 63 1.5× 16 496
Irina Thiry Belgium 7 339 1.2× 122 0.6× 24 0.2× 14 0.2× 174 4.1× 9 508

Countries citing papers authored by Jack K. Tung

Since Specialization
Citations

This map shows the geographic impact of Jack K. Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack K. Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack K. Tung more than expected).

Fields of papers citing papers by Jack K. Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack K. Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack K. Tung. The network helps show where Jack K. Tung may publish in the future.

Co-authorship network of co-authors of Jack K. Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Jack K. Tung. A scholar is included among the top collaborators of Jack K. Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack K. Tung. Jack K. Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, Katie, Amy B. Wilfert, Sai Chen, et al.. (2025). Abstract 692: Analytical validation of a tissue-free epigenomic assay for circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) detection in early-stage cancer. Cancer Research. 85(8_Supplement_1). 692–692. 1 indexed citations
2.
Espenschied, Carin R., Cátálin Bárbácioru, Bryan Lin, et al.. (2025). Association between epigenomic biomarkers and baseline clinical characteristics in patients with mCRPC treated with rucaparib in TRITON2.. Journal of Clinical Oncology. 43(16_suppl). 5086–5086.
3.
Gross, Andrew M., Jun Zhao, Katie Quinn, et al.. (2025). Abstract 5936: Landscape of epigenomic tumor fraction in large pan-cancer cfDNA cohort. Cancer Research. 85(8_Supplement_1). 5936–5936.
4.
Tung, Jack K., Michael S. Khodadoust, Youn H. Kim, et al.. (2023). Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor. Journal of Molecular Diagnostics. 25(6). 331–341.
5.
Tung, Jack K., et al.. (2021). Validation of a Next-Generation Sequencing–Based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay. Journal of Molecular Diagnostics. 23(7). 805–815. 9 indexed citations
6.
Tung, Jack K., et al.. (2021). Accurate Detection and Quantification of FLT3 Internal Tandem Duplications in Clinical Hybrid Capture Next-Generation Sequencing Data. Journal of Molecular Diagnostics. 23(10). 1404–1413. 10 indexed citations
7.
Hogan, Catherine A., Natasha Garamani, Andrew S. Lee, et al.. (2020). Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens. Journal of Clinical Microbiology. 58(8). 53 indexed citations
8.
Tung, Jack K., et al.. (2020). An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer. Molecular Case Studies. 6(4). a005140–a005140. 1 indexed citations
9.
Yu, Shan Ping, Jack K. Tung, Zheng Wei, et al.. (2019). Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke. Journal of Neuroscience. 39(33). 6571–6594. 71 indexed citations
10.
Zhang, James Y., Jack K. Tung, Shan Ping Yu, et al.. (2019). Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity. Journal of Neuroscience Research. 98(3). 481–490. 10 indexed citations
11.
Laxpati, Nealen G., Claire‐Anne Gutekunst, Mark Connolly, et al.. (2019). A Machine Learning Approach to Characterize the Modulation of the Hippocampal Rhythms Via Optogenetic Stimulation of the Medial Septum. International Journal of Neural Systems. 29(10). 1950020–1950020. 14 indexed citations
12.
Tung, Jack K., et al.. (2017). Motoneuron activity is required for enhancements in functional recovery after peripheral nerve injury in exercised female mice. Journal of Neuroscience Research. 98(3). 448–457. 23 indexed citations
13.
14.
Tung, Jack K., et al.. (2016). A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy. Vaccine. 34(19). 2225–2232. 19 indexed citations
15.
Tung, Jack K., Ken Berglund, & Robert E. Gross. (2016). Optogenetic Approaches for Controlling Seizure Activity. Brain stimulation. 9(6). 801–810. 21 indexed citations
16.
Gutekunst, Claire‐Anne, et al.. (2016). C3 transferase gene therapy for continuous conditional RhoA inhibition. Neuroscience. 339. 308–318. 13 indexed citations
17.
Berglund, Ken, Jack K. Tung, Bryan Higashikubo, et al.. (2016). Combined Optogenetic and Chemogenetic Control of Neurons. Methods in molecular biology. 1408. 207–225. 25 indexed citations
18.
Tung, Jack K., et al.. (2016). Bioluminescence imaging in live cells and animals. Neurophotonics. 3(2). 1–1. 60 indexed citations
19.
Tung, Jack K., et al.. (2015). Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable and hardware-independent optogenetic inhibition. Scientific Reports. 5(1). 14366–14366. 46 indexed citations
20.
Zhou, Meixia, Yongping Crawford, Jack K. Tung, et al.. (2011). Decreasing lactate level and increasing antibody production in Chinese Hamster Ovary cells (CHO) by reducing the expression of lactate dehydrogenase and pyruvate dehydrogenase kinases. Journal of Biotechnology. 153(1-2). 27–34. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darin Zerti Breakdown of academic impact, for papers by Philip Kusk Breakdown of academic impact, for papers by G. Cederquist Breakdown of academic impact, for papers by Ayuko Sakane Breakdown of academic impact, for papers by Hui Gai Breakdown of academic impact, for papers by Stephan Riesenberg Breakdown of academic impact, for papers by María Duran‐Moreno Breakdown of academic impact, for papers by Gokul N. Ramadoss Breakdown of academic impact, for papers by Diderik Tirefort Breakdown of academic impact, for papers by Irina Thiry
Rankless by CCL
2026